使用预测性生物标志物来选择晚期结直肠癌患者接受表皮生长因子受体抗体治疗。 - Suppr

Suppr

超能文献

Using predictive biomarkers to select patients with advanced colorectal cancer for treatment with epidermal growth factor receptor antibodies.

作者信息

Wong Rachel, Cunningham David

出版信息

J Clin Oncol. 2008 Dec 10;26(35):5668-70. doi: 10.1200/JCO.2008.19.5024. Epub 2008 Nov 10.

DOI:10.1200/JCO.2008.19.5024

PMID:19001346

Abstract

摘要

相似文献

Using predictive biomarkers to select patients with advanced colorectal cancer for treatment with epidermal growth factor receptor antibodies.使用预测性生物标志物来选择晚期结直肠癌患者接受表皮生长因子受体抗体治疗。

J Clin Oncol. 2008 Dec 10;26(35):5668-70. doi: 10.1200/JCO.2008.19.5024. Epub 2008 Nov 10.

Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer.野生型BRAF是转移性结直肠癌对帕尼单抗或西妥昔单抗产生反应所必需的。

J Clin Oncol. 2008 Dec 10;26(35):5705-12. doi: 10.1200/JCO.2008.18.0786. Epub 2008 Nov 10.

Relationship between colorectal cancer biomarkers and response to epidermal growth factor receptor monoclonal antibodies.结直肠癌生物标志物与表皮生长因子受体单克隆抗体反应之间的关系

J Clin Oncol. 2010 Oct 1;28(28):e529-31; author reply e532-e533. doi: 10.1200/JCO.2010.29.5626. Epub 2010 Aug 2.

The forest and the trees: pathways and proteins as colorectal cancer biomarkers.森林与树木：作为结直肠癌生物标志物的通路与蛋白质

J Clin Oncol. 2009 Dec 10;27(35):5866-7. doi: 10.1200/JCO.2009.24.8013. Epub 2009 Nov 2.

Are we ready to restrict EGFR therapy to quadruple-negative colorectal cancer?我们准备好将表皮生长因子受体（EGFR）治疗限制于四阴性结直肠癌了吗？

Lancet Oncol. 2010 Nov;11(11):1020-1. doi: 10.1016/S1470-2045(10)70211-4.

Analysis of PTEN, BRAF, and EGFR status in determining benefit from cetuximab therapy in wild-type KRAS metastatic colon cancer.分析PTEN、BRAF和EGFR状态以确定野生型KRAS转移性结肠癌患者从西妥昔单抗治疗中获益的情况。

J Clin Oncol. 2009 Dec 10;27(35):5924-30. doi: 10.1200/JCO.2008.21.6796. Epub 2009 Nov 2.

Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy?结直肠癌的预后与预测性分子生物标志物：抗 EGFR 治疗是否需要 KRAS 和 BRAF 野生型状态？

Cancer Treat Rev. 2010 Nov;36 Suppl 3:S56-61. doi: 10.1016/S0305-7372(10)70021-9.

EGFR FISH in colorectal cancer: what is the current reality?结直肠癌中的表皮生长因子受体荧光原位杂交技术：当前现状如何？

Lancet Oncol. 2008 May;9(5):402-3. doi: 10.1016/S1470-2045(08)70109-8.

KRAS mutation signature in colorectal tumors significantly overlaps with the cetuximab response signature.结直肠癌肿瘤中的KRAS突变特征与西妥昔单抗反应特征显著重叠。

J Clin Oncol. 2008 May 1;26(13):2228-30; author reply 2230-1. doi: 10.1200/JCO.2007.15.9186.

EGFR antibodies in colorectal cancer: where do they belong?结直肠癌中的表皮生长因子受体抗体：它们的归属在哪里？

J Clin Oncol. 2010 Nov 1;28(31):4668-70. doi: 10.1200/JCO.2010.29.3407. Epub 2010 Oct 4.

引用本文的文献

Exosomal microRNAs in regulation of tumor cells resistance to apoptosis.外泌体微小RNA在调节肿瘤细胞凋亡抗性中的作用

Biochem Biophys Rep. 2024 Jan 17;37:101644. doi: 10.1016/j.bbrep.2024.101644. eCollection 2024 Mar.

Regulation of IFN-γ-mediated PD-L1 expression by MYC in colorectal cancer with wild-type KRAS and TP53 and its clinical implications.MYC对野生型KRAS和TP53的结直肠癌中IFN-γ介导的PD-L1表达的调控及其临床意义

Front Pharmacol. 2022 Dec 13;13:1022129. doi: 10.3389/fphar.2022.1022129. eCollection 2022.

Cutoff of 25% for Ki67 expression is a good classification tool for prognosis in colorectal cancer in the AJCC‑8 stratification.Ki67 表达 25% 的截断值是 AJCC-8 分层中结直肠癌预后的一个良好分类工具。

Oncol Rep. 2020 Apr;43(4):1187-1198. doi: 10.3892/or.2020.7511. Epub 2020 Feb 21.

KRAS and NRAS mutational gene profile of metastatic colorectal cancer patients in Jordan.约旦转移性结直肠癌患者 KRAS 和 NRAS 基因突变基因谱。

PLoS One. 2019 Dec 27;14(12):e0226473. doi: 10.1371/journal.pone.0226473. eCollection 2019.

Exosomal miRNA: Small Molecules, Big Impact in Colorectal Cancer.外泌体微小RNA：小分子，对结直肠癌有重大影响

J Oncol. 2019 Oct 13;2019:8585276. doi: 10.1155/2019/8585276. eCollection 2019.

L-Lactate dehydrogenase B may be a predictive marker for sensitivity to anti-EGFR monoclonal antibodies in colorectal cancer cell lines.L-乳酸脱氢酶B可能是结直肠癌细胞系中抗表皮生长因子受体单克隆抗体敏感性的预测标志物。

Oncol Lett. 2019 May;17(5):4710-4716. doi: 10.3892/ol.2019.10075. Epub 2019 Feb 26.

Molecular characterization and biomarker identification in colorectal cancer: Toward realization of the precision medicine dream.结直肠癌的分子特征与生物标志物鉴定：迈向精准医学梦想的实现

Cancer Manag Res. 2018 Nov 19;10:5895-5908. doi: 10.2147/CMAR.S162967. eCollection 2018.

Diverse Long RNAs Are Differentially Sorted into Extracellular Vesicles Secreted by Colorectal Cancer Cells.不同的长 RNA 被差异化分拣到结直肠癌细胞分泌的细胞外囊泡中。

Cell Rep. 2018 Oct 16;25(3):715-725.e4. doi: 10.1016/j.celrep.2018.09.054.

Noninvasive Biomarkers of Colorectal Cancer: Role in Diagnosis and Personalised Treatment Perspectives.结直肠癌的非侵入性生物标志物：在诊断和个性化治疗前景中的作用

Gastroenterol Res Pract. 2018 Jun 13;2018:2397863. doi: 10.1155/2018/2397863. eCollection 2018.

Improved detection of BRAF V600E using allele-specific PCR coupled with external and internal controllers.采用等位基因特异性 PCR 联合外源性和内源性对照物提高 BRAF V600E 的检测率。

Sci Rep. 2017 Oct 23;7(1):13817. doi: 10.1038/s41598-017-14140-2.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验